Industry: Medical Devices & Consumables
Published Date: 2025-07-04
Pages: 120 Pages
Report ld: 4783835
Request Sample
Customized Report
Hematology Controls and Calibrators Market Size(US$)

CAGR 2025-2031
6.2%
Market Size,2031
USD 681
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Hematology Controls and Calibrators was estimated to be worth US$ 447 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hematology Controls and Calibrators cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Hematology Controls and Calibrators are standard substances used to ensure the accuracy and reliability of blood analyzer (such as blood routine testing equipment) test results. Controls simulate the cellular components of real blood samples, such as red blood cells, white blood cells, and platelets, and are used for daily monitoring of instrument performance stability, such as precision and accuracy; Calibrators are specific analytes with known concentrations (such as hemoglobin, MCV) used to calibrate instrument detection parameters and eliminate systematic errors.
North American market for Hematology Controls and Calibrators was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hematology Controls and Calibrators was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Hematology Controls and Calibrators was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Hematology Controls and Calibrators include Bio-Rad, Streck, Thermo Fisher Scientific, Randox Laboratories, Sysmex, Fortress Diagnostics, Bio-Techne, Diatron, Changchun DIRUI, Shenzhen Mindray, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Hematology Controls and Calibrators, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hematology Controls and Calibrators by region & country, by Type, and by Application.
The Hematology Controls and Calibrators market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Controls and Calibrators.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hematology Controls and Calibrators manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hematology Controls and Calibrators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hematology Controls and Calibrators in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hematology Controls and Calibrators Product Introduction
1.2 Global Hematology Controls and Calibrators Market Size Forecast
1.2.1 Global Hematology Controls and Calibrators Sales Value (2020-2031)
1.2.2 Global Hematology Controls and Calibrators Sales Volume (2020-2031)
1.2.3 Global Hematology Controls and Calibrators Sales Price (2020-2031)
1.3 Hematology Controls and Calibrators Market Trends & Drivers
1.3.1 Hematology Controls and Calibrators Industry Trends
1.3.2 Hematology Controls and Calibrators Market Drivers & Opportunity
1.3.3 Hematology Controls and Calibrators Market Challenges
1.3.4 Hematology Controls and Calibrators Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hematology Controls and Calibrators Players Revenue Ranking (2024)
2.2 Global Hematology Controls and Calibrators Revenue by Company (2020-2025)
2.3 Global Hematology Controls and Calibrators Players Sales Volume Ranking (2024)
2.4 Global Hematology Controls and Calibrators Sales Volume by Company Players (2020-2025)
2.5 Global Hematology Controls and Calibrators Average Price by Company (2020-2025)
2.6 Key Manufacturers Hematology Controls and Calibrators Manufacturing Base and Headquarters
2.7 Key Manufacturers Hematology Controls and Calibrators Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hematology Controls and Calibrators
2.9 Hematology Controls and Calibrators Market Competitive Analysis
2.9.1 Hematology Controls and Calibrators Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Hematology Controls and Calibrators Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hematology Controls and Calibrators as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 High Level
3.1.2 Medium Level
3.1.3 Low Level
3.2 Global Hematology Controls and Calibrators Sales Value by Type
3.2.1 Global Hematology Controls and Calibrators Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Hematology Controls and Calibrators Sales Value, by Type (2020-2031)
3.2.3 Global Hematology Controls and Calibrators Sales Value, by Type (%) (2020-2031)
3.3 Global Hematology Controls and Calibrators Sales Volume by Type
3.3.1 Global Hematology Controls and Calibrators Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Hematology Controls and Calibrators Sales Volume, by Type (2020-2031)
3.3.3 Global Hematology Controls and Calibrators Sales Volume, by Type (%) (2020-2031)
3.4 Global Hematology Controls and Calibrators Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Laboratory
4.2 Global Hematology Controls and Calibrators Sales Value by Application
4.2.1 Global Hematology Controls and Calibrators Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Hematology Controls and Calibrators Sales Value, by Application (2020-2031)
4.2.3 Global Hematology Controls and Calibrators Sales Value, by Application (%) (2020-2031)
4.3 Global Hematology Controls and Calibrators Sales Volume by Application
4.3.1 Global Hematology Controls and Calibrators Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Hematology Controls and Calibrators Sales Volume, by Application (2020-2031)
4.3.3 Global Hematology Controls and Calibrators Sales Volume, by Application (%) (2020-2031)
4.4 Global Hematology Controls and Calibrators Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Hematology Controls and Calibrators Sales Value by Region
5.1.1 Global Hematology Controls and Calibrators Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Hematology Controls and Calibrators Sales Value by Region (2020-2025)
5.1.3 Global Hematology Controls and Calibrators Sales Value by Region (2026-2031)
5.1.4 Global Hematology Controls and Calibrators Sales Value by Region (%), (2020-2031)
5.2 Global Hematology Controls and Calibrators Sales Volume by Region
5.2.1 Global Hematology Controls and Calibrators Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Hematology Controls and Calibrators Sales Volume by Region (2020-2025)
5.2.3 Global Hematology Controls and Calibrators Sales Volume by Region (2026-2031)
5.2.4 Global Hematology Controls and Calibrators Sales Volume by Region (%), (2020-2031)
5.3 Global Hematology Controls and Calibrators Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Hematology Controls and Calibrators Sales Value, 2020-2031
5.4.2 North America Hematology Controls and Calibrators Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Hematology Controls and Calibrators Sales Value, 2020-2031
5.5.2 Europe Hematology Controls and Calibrators Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Hematology Controls and Calibrators Sales Value, 2020-2031
5.6.2 Asia Pacific Hematology Controls and Calibrators Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Hematology Controls and Calibrators Sales Value, 2020-2031
5.7.2 South America Hematology Controls and Calibrators Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hematology Controls and Calibrators Sales Value, 2020-2031
5.8.2 Middle East & Africa Hematology Controls and Calibrators Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hematology Controls and Calibrators Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Hematology Controls and Calibrators Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hematology Controls and Calibrators Sales Value, 2020-2031
6.2.2 Key Countries/Regions Hematology Controls and Calibrators Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Hematology Controls and Calibrators Sales Value, 2020-2031
6.3.2 United States Hematology Controls and Calibrators Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Hematology Controls and Calibrators Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Hematology Controls and Calibrators Sales Value, 2020-2031
6.4.2 Europe Hematology Controls and Calibrators Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Hematology Controls and Calibrators Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Hematology Controls and Calibrators Sales Value, 2020-2031
6.5.2 China Hematology Controls and Calibrators Sales Value by Type (%), 2024 VS 2031
6.5.3 China Hematology Controls and Calibrators Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Hematology Controls and Calibrators Sales Value, 2020-2031
6.6.2 Japan Hematology Controls and Calibrators Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Hematology Controls and Calibrators Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Hematology Controls and Calibrators Sales Value, 2020-2031
6.7.2 South Korea Hematology Controls and Calibrators Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Hematology Controls and Calibrators Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Hematology Controls and Calibrators Sales Value, 2020-2031
6.8.2 Southeast Asia Hematology Controls and Calibrators Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Hematology Controls and Calibrators Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Hematology Controls and Calibrators Sales Value, 2020-2031
6.9.2 India Hematology Controls and Calibrators Sales Value by Type (%), 2024 VS 2031
6.9.3 India Hematology Controls and Calibrators Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Bio-Rad
7.1.1 Bio-Rad Company Information
7.1.2 Bio-Rad Introduction and Business Overview
7.1.3 Bio-Rad Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Bio-Rad Hematology Controls and Calibrators Product Offerings
7.1.5 Bio-Rad Recent Development
7.2 Streck
7.2.1 Streck Company Information
7.2.2 Streck Introduction and Business Overview
7.2.3 Streck Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Streck Hematology Controls and Calibrators Product Offerings
7.2.5 Streck Recent Development
7.3 Thermo Fisher Scientific
7.3.1 Thermo Fisher Scientific Company Information
7.3.2 Thermo Fisher Scientific Introduction and Business Overview
7.3.3 Thermo Fisher Scientific Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Thermo Fisher Scientific Hematology Controls and Calibrators Product Offerings
7.3.5 Thermo Fisher Scientific Recent Development
7.4 Randox Laboratories
7.4.1 Randox Laboratories Company Information
7.4.2 Randox Laboratories Introduction and Business Overview
7.4.3 Randox Laboratories Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Randox Laboratories Hematology Controls and Calibrators Product Offerings
7.4.5 Randox Laboratories Recent Development
7.5 Sysmex
7.5.1 Sysmex Company Information
7.5.2 Sysmex Introduction and Business Overview
7.5.3 Sysmex Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sysmex Hematology Controls and Calibrators Product Offerings
7.5.5 Sysmex Recent Development
7.6 Fortress Diagnostics
7.6.1 Fortress Diagnostics Company Information
7.6.2 Fortress Diagnostics Introduction and Business Overview
7.6.3 Fortress Diagnostics Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Fortress Diagnostics Hematology Controls and Calibrators Product Offerings
7.6.5 Fortress Diagnostics Recent Development
7.7 Bio-Techne
7.7.1 Bio-Techne Company Information
7.7.2 Bio-Techne Introduction and Business Overview
7.7.3 Bio-Techne Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Bio-Techne Hematology Controls and Calibrators Product Offerings
7.7.5 Bio-Techne Recent Development
7.8 Diatron
7.8.1 Diatron Company Information
7.8.2 Diatron Introduction and Business Overview
7.8.3 Diatron Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Diatron Hematology Controls and Calibrators Product Offerings
7.8.5 Diatron Recent Development
7.9 Changchun DIRUI
7.9.1 Changchun DIRUI Company Information
7.9.2 Changchun DIRUI Introduction and Business Overview
7.9.3 Changchun DIRUI Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Changchun DIRUI Hematology Controls and Calibrators Product Offerings
7.9.5 Changchun DIRUI Recent Development
7.10 Shenzhen Mindray
7.10.1 Shenzhen Mindray Company Information
7.10.2 Shenzhen Mindray Introduction and Business Overview
7.10.3 Shenzhen Mindray Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Shenzhen Mindray Hematology Controls and Calibrators Product Offerings
7.10.5 Shenzhen Mindray Recent Development
7.11 Sichuan ZCMT
7.11.1 Sichuan ZCMT Company Information
7.11.2 Sichuan ZCMT Introduction and Business Overview
7.11.3 Sichuan ZCMT Hematology Controls and Calibrators Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Sichuan ZCMT Hematology Controls and Calibrators Product Offerings
7.11.5 Sichuan ZCMT Recent Development
8 Industry Chain Analysis
8.1 Hematology Controls and Calibrators Industrial Chain
8.2 Hematology Controls and Calibrators Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hematology Controls and Calibrators Sales Model
8.5.2 Sales Channel
8.5.3 Hematology Controls and Calibrators Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 719 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-12
Pages: 159
USD 4900.00
(Single User License)
The global Hematology Controls and Calibrators market size was US$ 475 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published Date: 2026-03-12
Pages: 93
USD 4250.00
(Single User License)
The global Hematology Controls and Calibrators market was valued at US$ 475 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-03-12
Pages: 119
USD 2900.00
(Single User License)
The global market for Hematology Controls and Calibrators was estimated to be worth US$ 475 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published Date: 2026-03-09
Pages: 123
USD 3950.00
(Single User License)
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 681 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published Date: 2025-07-04
Pages: 149
USD 4900.00
(Single User License)
The global market for Hematology Controls and Calibrators was valued at US$ 447 million in the year 2024 and is projected to reach a revised size of US$ 681 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published Date: 2025-07-04
Pages: 90
USD 2900.00
(Single User License)
The global Hematology Controls and Calibrators market size was US$ 447 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published Date: 2025-07-04
Pages: 94
USD 4250.00
(Single User License)
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 719 million by 2032, at a CAGR of 6.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-12
Pages: 159
The global Hematology Controls and Calibrators market size was US$ 475 million in 2025 and is forecast to reach a readjusted size of US$ 719 million by 2032 with a CAGR of 6.2% during the forecast period 2026-2032.
Published: 2026-03-12
Pages: 93
The global Hematology Controls and Calibrators market was valued at US$ 475 million in 2025 and is anticipated to reach US$ 719 million by 2032, at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-03-12
Pages: 119
The global market for Hematology Controls and Calibrators was estimated to be worth US$ 475 million in 2025 and is projected to reach US$ 719 million, growing at a CAGR of 6.2% from 2026 to 2032.
Published: 2026-03-09
Pages: 123
The global Hematology Controls and Calibrators market is projected to grow from US$ 475 million in 2025 to US$ 681 million by 2031, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Published: 2025-07-04
Pages: 149
The global market for Hematology Controls and Calibrators was valued at US$ 447 million in the year 2024 and is projected to reach a revised size of US$ 681 million by 2031, growing at a CAGR of 6.2% during the forecast period.
Published: 2025-07-04
Pages: 90
The global Hematology Controls and Calibrators market size was US$ 447 million in 2024 and is forecast to a readjusted size of US$ 681 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.
Published: 2025-07-04
Pages: 94
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now